A BRIEF REVIEW OF NUCLEAR-FACTOR-KAPPA-B IN SILICO STUDIES
DOI:
https://doi.org/10.20319/icrlsh.2024.94103Keywords:
Inflammation, Nuclear Factor Kappa B, Signalling Pathway, Cancer, In Silico, Immune ResponseAbstract
This mini-review briefly summarises the use of computer-aided tools and research developments in nuclear-factor-kappa-b (NF-kB) within the last ten years. Computer-aided or in silico studies on the NF-kB complex give hope for developing potential therapeutic targets for various diseases involving the NF-KB protein. In silico investigations, as opposed to in vivo and in vitro research, have the advantages of being more exact and time-efficient and eliminating the utilisation of humans and animals. It provides a framework for evaluating the activity of prospective therapies against molecular targets, predicting their activity based on a compound's structure even before it has been synthesised for additional in vitro and in vivo research. Targeting NF-kB protein is crucial as it can implicate many diseases, such as immune and inflammatory responses, involved in stress response, cellular growth, and apoptosis. These findings are critical for directing future research into the NF-kB protein, its function in human disorders, and prospective therapeutic targets.
References
Ali A, Shah FA, Zeb A, Malik I, Alvi AM, Alkury LT, Rashid S, Hussain I, Ullah N, Khan AU, Koh PO (2020) NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—a reprofiling approach. Frontiers in molecular neuroscience 13:33
Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R (2021) NF-κB: at the borders of autoimmunity and inflammation. Frontiers in Immunology 3169
Begalli F, Bennett J, Capece D, Verzella D, D'Andrea D, Tornatore L, Franzoso G (2017) Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity. Biomedicines 5(3):50
Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M (2004) Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. The EMBO journal 23(21):4202–4210
Brasier AR (2010) The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 86(2):211-218
Faes S, Dormond O. (2015) PI3K and AKT: unfaithful partners in cancer. International journal of molecular sciences. 16(9):21138-52.
Hayden MS, West AP, Ghosh S (2006) NF-kB and the immune response. Oncogene 25(51): 6758–80.
Deptala A, Bedner E, Gorczyca W, Darzynkiewicz Z (1998) Activation of nuclear factor kappa B (NF-kappa B) assayed by laser scanning cytometry (LSC). Cytometry 33(3):376-382
Gilmore TD, Herscovitch M (2006) Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25(51):6887-99
Hikmaranti M, Astiyani AM, Hasanah KM, Maghfiroh NM (2020) A Comparative Study of Gallic Acid, Ellagic Acid, Urolithin A, and Urolithin B with NF-κB Protein as Anti Type 2 Diabetes Mellitus by In Silico. JSMARTech: Journal of Smart Bioprospecting and Technology 1(2):031-5
Hira S, Saleem U, Anwar F, Raza Z, Rehman AU, Ahmad B (2020) In silico study and pharmacological evaluation of Eplerinone as an Anti-Alzheimer's drug in STZ-induced Alzheimer's disease model. ACS omega 5(23):13973-83
Jiang H, Fang J, Xing J, Wang L, Wang Q, Wang Y, Li Z, Liu R (2019) Tilianin mediates neuroprotection against ischemic injury by attenuating CaMKII-dependent mitochondrion-mediated apoptosis and MAPK/NF-κB signaling. Life sciences 216:233-45
Jin M, Duan J, Liu W, Ji J, Liu B, Zhang M (2021) Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells. Cancer cell international 21(1):1-0
Kaltschmidt B, Helweg LP, Greiner JF, Kaltschmidt C (2022) NF-κB in neurodegenerative diseases: Recent evidence from human genetics. Frontiers in Molecular Neuroscience 397
Kanan T, Kanan D, Al Shardoub EJ, Durdagi S (2021) Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model. J Mol Graph Model 108:107968
Latawa P, Chrisman BA (2021) Computational Modeling Framework to Analyse Synovial-Tissue Based Drug Targets and Diagnostic Biomarkers in Rheumatoid Arthritis. bioRxiv doi:https://doi.org/10.1101/2021.11.08.467813
Li WY, Yang F, Chen JH, Ren GF (2021) β-Caryophyllene Ameliorates MSU-Induced Gouty Arthritis and Inflammation Through Inhibiting NLRP3 and NF-κB Signal Pathway: In Silico and In Vivo. Front Pharmacol 12:651305
Liu T, Zhang L, Joo D, Sun SC (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2:17023
Murwanti R, Kholifah E, Sudarmanto BA, Hermawan A (2020) Effect of curcumin on NF-κB P105/50 expression on triple-negative breast cancer (TNBC) and its possible mechanism of action. AIP Conference Proceedings 2260:040024
Nandeesh R, Vijayakumar S, Munnolli A, Alreddy A, Veerapur VP, Chandramohan V, Manjunatha E (2018) Bioactive phenolic fraction of Citrus maxima abate lipopolysaccharide-induced sickness behaviour and anorexia in mice: In-silico molecular docking and dynamic studies of biomarkers against NF-κB. Biomedicine & Pharmacotherapy 108:1535-45
Shankar E, Weis MC, Avva J, Shukla S, Shukla M, Sreenath SN, Gupta S. (2019) Complex Systems Biology Approach in Connecting PI3K-Akt and NF-κB Pathways in Prostate Cancer. Cells. 8(3):201
Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-kappaB. Annual review of cell biology 10(1):405-55
Singh H, Sen R, Baltimore D, Sharp PA (1986) A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319(6049):154-158
Solt LA, May MJ (2008) The IkappaB kinase complex: master regulator of NF-kappaB signaling. Immunol Res 42(1-3):3-18
Sung MH, Simon R (2004) In silico simulation of inhibitor drug effects on nuclear factor-kappaB pathway dynamics. Mol Pharmacol 66(1):70-5
Uddin MZ, Paul A, Rakib A, Sami SA, Mahmud S, Rana MS, Hossain S, Tareq AM, Dutta M, Emran TB, Simal-Gandara J. (2021) Chemical profiles and pharmacological properties with in silico studies on elatostema papillosum wedd. Molecules 26(4):809
Wu ZH, Miyamoto S (2007) Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med (Berl) 85(11):1187-1202
Yu H, Lin L, Zhang Z, Zhang H, Hu H (2020) Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5(1):209
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of Published Articles
Author(s) retain the article copyright and publishing rights without any restrictions.
All published work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
